NCT04233125

Brief Summary

Osteonecrosis of the femoral head (ONFH) is difficult to treat as collapse frequently occurs after core decompression (CD). This may be due to the failure to provide structural support during revascularization and healing. Reports of polymethylmethacrylate (PMMA) packing of the femoral head after CD for ONFH have noted favorable results. This study was undertaken to determine whether the addition of PMMA packing to CD provides any benefit to progression-free survival (PFS) and conversion to total hip arthroplasty-free survival (CFS). Secondary objectives were to assess for differences in functional outcomes and predictive factors for progression of the disease.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 1997

Longer than P75 for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1997

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2005

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
12 years until next milestone

First Submitted

Initial submission to the registry

January 14, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
Last Updated

January 18, 2020

Status Verified

January 1, 2020

Enrollment Period

8 years

First QC Date

January 14, 2020

Last Update Submit

January 14, 2020

Conditions

Keywords

Femoral HeadHipCore DecompressionPolymethlymethacrylateCementProgressionSurvival

Outcome Measures

Primary Outcomes (1)

  • Progression Free Survival (PFS)

    Progression Free Survival (PFS) is defined as the length of time (reported in months) following surgery that participants have no signs of radiographic progression of femoral head osteonecrosis. Radiographic progression is defined as any degree of flattening or loss of spherical contour of the femoral head as detected on the radiographs or MRI. Appearance of a subchondral fracture (crescent sign) on radiographs or MRI was also considered a sign of progression.

    5 years

Secondary Outcomes (7)

  • Conversion Free Survival (CFS)

    5 years

  • Mean Harris Hip Score (HHS)

    baseline, 2 years post surgery, 5 years post surgery

  • Change in Harris Hip Score (HHS)

    baseline, 2 years post surgery

  • Mean Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    baseline, 2 years post surgery, 5 years post surgery

  • Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    baseline, 2 years post surgery

  • +2 more secondary outcomes

Study Arms (2)

Core Decompression (CD) Only

ACTIVE COMPARATOR

Participants in this group receive standard care

Procedure: Core Decompression

Added Polymethylmethacrylate (PMMA)

EXPERIMENTAL

Participants in this group receive standard care with an additional treatment

Procedure: Core DecompressionProcedure: PMMA augmentation

Interventions

Core Decompression

Added Polymethylmethacrylate (PMMA)Core Decompression (CD) Only

Polymethylmethacrylate (PMMA) augmentation

Added Polymethylmethacrylate (PMMA)

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging

You may not qualify if:

  • pre-existing collapse, subchondral fracture or degenerative changes of the hip

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OsteonecrosisDisease Progression

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2020

First Posted

January 18, 2020

Study Start

January 1, 1997

Primary Completion

January 1, 2005

Study Completion

January 1, 2008

Last Updated

January 18, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share